Back to Journals » Clinical and Experimental Gastroenterology » Volume 3

An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease

Authors Mathews S, Reid A, Tian C, Cai Q

Published 20 January 2010 Volume 2010:3 Pages 11—16

DOI https://doi.org/10.2147/CEG.S6355

Review by Single anonymous peer review

Peer reviewer comments 3


Sony Mathews, Ashley Reid, Chenlu Tian, Qiang Cai

Division of Digestive Diseases, Department of Medicine, Emory University, School of Medicine, Atlanta, GA, USA

Abstract: Gastroesophageal reflux disease (GERD) is a chronic, recurrent disease that affects nearly 19 million people in the US. The mainstay of therapy for GERD is acid suppression. Proton pump inhibitors (PPIs) are the most effective medication for both initial treatment and maintenance therapy of GERD. Pantoprazole, a first-generation PPI, was approved by the FDA in 2000 for the treatment of erosive esophagitis associated with GERD. It has been used in more than 100 different countries worldwide. It is one of the few PPIs available in multiple forms: a delayed-release oral capsule, oral suspension, and intravenous. Pantoprazole been shown to improve acid reflux-related symptoms, heal esophagitis, and improve health-related quality of life more effectively than histamine-2 receptor antagonists. Evaluated in over 100 clinical trials, pantoprazole has an excellent safety profile, is as efficacious as other PPIs, and has a low incidence of drug interactions. It has also been shown to be safe and effective in special patient populations, such as the elderly and those with renal or moderate liver disease.
Keywords: pantoprazole, GERD, esophagitis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]